When COVID-19 meets cancer: Navigating evolving evidence in a global pandemic

Designed as an educational programme to offer an expert opinion on the management of patients with COVID-19 and cancer, this unique webinar will present some practical experiences around the multi-disciplinary management of such patients.

Join us to understand the impact of the COVID-19 pandemic in the multi-disciplinary management of patients with cancer, to investigate current evidence surrounding vulnerability of cancer patients to the SARS-Cov-2 infection, and to explore changes in diagnostic and treatment algorithms across malignancies.

This meeting capitalises on the expertise of the OnCovid study investigator, the first multi-centre European study documenting outcomes of patients with both COVID-19 and cancer.

By attending this session, participants will be able to:

• Understand the clinical and pathophysiological basis of COVID-19 infection, with a particular focus on impact on cancer patients
• Appreciate the clinical and biologic factors that portend to disease severity and adverse outcome in patients with cancer and the virus
• Implement risk stratification in routine clinical practice and improve the decision making process in the setting of ongoing SARS-Cov-2 viral transmission in the community

Join in the conversation online #RSMLiveFollow us on Twitter: @RoySocMed

Registration for this webinar will close 2 hours prior to the start time. You will receive the webinar link 2 hours before the meeting. Late registrations will not be accepted.

Webinar recordings will be available for registered delegates up to 30 days after the live webinar, via Zoom. The link will be sent 24 hours after the webinar takes place. 

This webinar will be recorded and stored by the Royal Society of Medicine and may be distributed in future on various internet channels.